Tumor motion a key to lung cancer treatment
School of Medicine scientists have developed an apparatus designed to precisely target radiation therapy on a tumor that may move with breathing.
Vision finding could benefit Alzheimer’s treatment
Results from a School of Medicine visual-motion study may ultimately help patients with Alzheimer’s disease and dyslexia.
Supplements studied as way to limit macular degeneration
School of Medicine researchers are evaluating dietary supplements to determine if they can prevent damage from age-related macular degeneration.
Match game
Photo by Robert BostonThe University’s fourth-year medical students learned March 15 where they will do their residencies.
Anti-epileptic drugs may help prevent hearing loss
A group headed by a School of Medicine researcher has found that two anti-epileptic drugs can prevent permanent hearing loss in mice exposed to loud noises.
Belly fat may be linked to systemic inflammation
Belly fat may be an important promoter of the inflammation that plays a role in diabetes, heart disease and other disorders, School of Medicine researchers find.
Can an omega-3 fatty acid slow the progression of Alzheimer’s disease?
Eating fish may help reduce the risk for dementia.Nutritionists have long endorsed fish as part of a heart-healthy diet, and now some studies suggest that omega-3 fatty acids found in the oil of certain fish may also benefit the brain by lowering the risk of Alzheimer’s disease. In order to test whether docosahexaenoic acid (DHA), an omega-3 fatty acid, can impact the progression of Alzheimer’s disease, researchers at the School of Medicine and Saint Louis University School of Medicine will evaluate DHA in a clinical trial sponsored by the National Institute on Aging (NIA).
Nanoparticles can track cells deep within living organisms
This image combines three MRI scans of a mouse: one is a typical scan showing internal organs, and the second two are scans tuned to the frequency of fluorine-laced nanoparticles (colored red and green).Nanoparticles developed by Washington University scientists in the Siteman Center of Cancer Nanotechnology Excellence could soon allow researchers and physicians to directly track cells used in medical treatments using unique signatures from the ingested nanoparticle beacons. The nanoparticles contain a compound that can be detected by MRI scanners, and the researchers believe nanoparticle-labeled cells could be used to evaluate cancerous tumors and many medical therapies.
Nichols appointed to Carl F. Cori professorship
Colin G. Nichols, Ph.D., has become the first Carl F. Cori Professor at the School of Medicine.
Light-activated compound slows seizure-like firing pattern, may help epileptics
School of Medicine researchers hope to one day combine a new drug with a small implanted light to stop seizures in patients with epilepsy.
View More Stories